Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis
- PMID: 3909319
- DOI: 10.1093/clinids/7.supplement_4.s635
Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis
Abstract
Aztreonam (SQ 26,776), a new monocyclic beta-lactam agent, was compared with several frequently used antibiotics in therapy for three types of experimental meningitis in rabbits and for experimental Escherichia coli cerebritis in rats. Aztreonam was highly active against common gram-negative meningeal pathogens in vitro (all minimal bactericidal concentrations less than or equal to 0.125 microgram/ml), including ampicillin-sensitive and ampicillin-resistant strains of Haemophilus influenzae, E. coli, and meningococci. In both rabbits and rats, serum concentrations of all antibiotics evaluated closely approximated concentrations found in humans receiving standard parenteral regimens. The percent penetration of aztreonam into purulent rabbit cerebrospinal fluid was 23%. In experimental meningitis, aztreonam was more rapidly bactericidal than ampicillin in meningitis due to ampicillin-sensitive H. influenzae, than ampicillin or chloramphenicol in meningitis due to ampicillin-resistant H. influenzae, and than gentamicin in meningitis due to E. coli. Aztreonam also reduced concentrations of E. coli in rat brain as rapidly as did gentamicin during therapy for experimental cerebritis, the early stage of brain abscess formation.
Similar articles
-
Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.Antimicrob Agents Chemother. 1983 Nov;24(5):682-8. doi: 10.1128/AAC.24.5.682. Antimicrob Agents Chemother. 1983. PMID: 6362552 Free PMC article.
-
Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.Antimicrob Agents Chemother. 1982 Oct;22(4):652-6. doi: 10.1128/AAC.22.4.652. Antimicrob Agents Chemother. 1982. PMID: 6217785 Free PMC article.
-
Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.Antimicrob Agents Chemother. 1985 Apr;27(4):655-6. doi: 10.1128/AAC.27.4.655. Antimicrob Agents Chemother. 1985. PMID: 3890733 Free PMC article.
-
[Treatment of central nervous system infections].Brux Med. 1973 May;53(5):311-9. Brux Med. 1973. PMID: 4582242 Review. French. No abstract available.
-
Management of bacterial meningitis in infants and children. Current status and future prospects.Am J Med. 1984 May 15;76(5A):215-23. doi: 10.1016/0002-9343(84)90267-5. Am J Med. 1984. PMID: 6372473 Review.
Cited by
-
Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1986 Nov;30(5):701-4. doi: 10.1128/AAC.30.5.701. Antimicrob Agents Chemother. 1986. PMID: 3099641 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical